126 related articles for article (PubMed ID: 38528823)
1. Intra-pancreatic fat is associated with continuous glucose monitoring metrics.
Liu Y; Kimita W; Shamaitijiang X; Skudder-Hill L; Sequeira-Bisson IR; Petrov MS
Diabetes Obes Metab; 2024 Jun; 26(6):2359-2367. PubMed ID: 38528823
[TBL] [Abstract][Full Text] [Related]
2. Associations between intra-pancreatic fat deposition and circulating levels of cytokines.
Singh RG; Nguyen NN; Cervantes A; Alarcon Ramos GC; Cho J; Petrov MS
Cytokine; 2019 Aug; 120():107-114. PubMed ID: 31054479
[TBL] [Abstract][Full Text] [Related]
3. Serum lipid profile as a biomarker of intra-pancreatic fat deposition: A nested cross-sectional study.
Singh RG; Nguyen NN; Cervantes A; Cho J; Petrov MS
Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):956-964. PubMed ID: 31353204
[TBL] [Abstract][Full Text] [Related]
4. Associations between Intra-Pancreatic Fat Deposition, Pancreas Size, and Pancreatic Enzymes in Health and after an Attack of Acute Pancreatitis.
Ko J; Skudder-Hill L; Priya S; Kimita W; Bharmal SH; Petrov MS
Obes Facts; 2022; 15(1):70-82. PubMed ID: 34753126
[TBL] [Abstract][Full Text] [Related]
5. Intra-pancreatic fat deposition as a modifier of the relationship between habitual dietary fat intake and insulin resistance.
Ko J; Skudder-Hill L; Tarrant C; Kimita W; Bharmal SH; Petrov MS
Clin Nutr; 2021 Jul; 40(7):4730-4737. PubMed ID: 34237700
[TBL] [Abstract][Full Text] [Related]
6. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
7. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
Murphy HR
Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
[TBL] [Abstract][Full Text] [Related]
8. Associations of Intrapancreatic Fat Deposition With Incident Diseases of the Exocrine and Endocrine Pancreas: A UK Biobank Prospective Cohort Study.
Dong X; Zhu Q; Yuan C; Wang Y; Ma X; Shi X; Chen W; Dong Z; Chen L; Shen Q; Xu H; Ding Y; Gong W; Xiao W; Wang S; Li W; Lu G
Am J Gastroenterol; 2024 Jun; 119(6):1158-1166. PubMed ID: 38587286
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
11. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
Turner LV; Marak MC; Gal RL; Calhoun P; Li Z; Jacobs PG; Clements MA; Martin CK; Doyle FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Riddell MC;
Diabetologia; 2024 Jun; 67(6):1009-1022. PubMed ID: 38502241
[TBL] [Abstract][Full Text] [Related]
12. G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe.
Acciaroli G; Parkin CG; Thomas R; Layne J; Norman GJ; Leone K
Diabet Med; 2023 Jun; 40(6):e15093. PubMed ID: 36951684
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
[TBL] [Abstract][Full Text] [Related]
14. Remnant cholesterol, but not low-density lipoprotein cholesterol, is associated with intra-pancreatic fat deposition.
Skudder-Hill L; Sequeira-Bisson IR; Ko J; Cho J; Poppitt SD; Petrov MS
Diabetes Obes Metab; 2023 Nov; 25(11):3337-3346. PubMed ID: 37529874
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic enzymes and abdominal adipose tissue distribution in new-onset prediabetes/diabetes after acute pancreatitis.
Ko J; Skudder-Hill L; Cho J; Bharmal SH; Petrov MS
World J Gastroenterol; 2021 Jun; 27(23):3357-3371. PubMed ID: 34163117
[TBL] [Abstract][Full Text] [Related]
16. Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.
Ruan Y; Zhong J; Chen R; Zhang Z; Liu D; Sun J; Chen H
J Diabetes Res; 2021; 2021():5551216. PubMed ID: 34136580
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
[No Abstract] [Full Text] [Related]
18. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of dyslipidemia states associated with fat in the pancreas.
Skudder-Hill L; Coffey S; Sequeira-Bisson IR; Ko J; Poppitt SD; Petrov MS
Diabetes Metab Syndr; 2023 Nov; 17(11):102881. PubMed ID: 37862954
[TBL] [Abstract][Full Text] [Related]
20. Dietary carbohydrate intake and insulin traits in individuals after acute pancreatitis: Effect modification by intra-pancreatic fat deposition.
Ko J; Kimita W; Skudder-Hill L; Li X; Priya S; Bharmal SH; Cho J; Petrov MS
Pancreatology; 2021 Mar; 21(2):353-362. PubMed ID: 33563551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
